TFCCX
Price
$18.96
Change
-$0.46 (-2.37%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

TFCCX vs VFINX

Header iconTFCCX vs VFINX Comparison
Open Charts TFCCX vs VFINXBanner chart's image
Touchstone Large Cap C
Price$18.96
Change-$0.46 (-2.37%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
TFCCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TFCCX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFCCX is a Buy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. TFCCX (302M). VFINX pays higher dividends than TFCCX: VFINX (1.24) vs TFCCX (0.00). TFCCX was incepted earlier than VFINX: TFCCX (10 years) vs VFINX (48 years). TFCCX is a more actively managed with annual turnover of: 19.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than TFCCX: VFINX (0) vs TFCCX (2500). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. TFCCX (13.37). VFINX return over 5 years is better than : 88.65 vs. TFCCX (38.52).
TFCCXVFINXTFCCX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years48 years-
Gain YTD13.30227.27549%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets302M1.37T0%
Annual Yield % from dividends0.001.24-
Returns for 1 year13.3727.6348%
Returns for 3 years5.5430.9918%
Returns for 5 years38.5288.6543%
Returns for 10 years81.28193.6242%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc